SURMODICS INC — Director's Dealing 2018

Nov 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-11-09

Reporting Person: Stich Joseph J. (VP and GM, IVD)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-09	Common Stock	S	200	$62.07	Disposed	52008	Direct
2018-11-09	Common Stock	S	1046	$63.6076	Disposed	50962	Direct
2018-11-09	Common Stock	S	754	$64.4499	Disposed	50208	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.

F2: Includes 289 shares acquired through the Employee Stock Purchase Plan for the phase ending August 31, 2018.

F3: Reflects the weighted average price of 1,046 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 9, 2018 with sale prices ranging from $63.18 to $64.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Reflects the weighted average price of 754 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 9, 2018 with sale prices ranging from $64.32 to $64.995 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.